𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of rituximab and chemotherapy in aggressive B-cell lymphoma: A preliminary report of dose-adjusted EPOCH-R

✍ Scribed by Wyndham H Wilson; Martin Gutierrez; Paula O'Connor; Stanley Frankel; Elaine Jaffe; Bruce A Chabner; Michael L Grossbard


Book ID
114481153
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
95 KB
Volume
29
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rituximab in cutaneous B-cell lymphoma:
✍ R.A. Sabroe; F.J. Child; A.J. Woolford; M.F. Spittle; R. Russell-Jones πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 416 KB

We report two patients with primary cutaneous B-cell lymphoma who were treated with rituximab, a new anti-CD20 monoclonal antibody. The first patient, who had a diffuse large B-cell lymphoma of the lower leg, achieved an 85% improvement. The second patient, who had a primary cutaneous B-cell lymphom